Elizabeth D. Phillips, Vice President of Human Resources at Kewaunee Scientific Corp (NASDAQ:KEQU), recently sold 1,850 shares of the company's common stock. The shares were sold at an average price of $54.17, amounting to a total transaction value of $100,214. Following this sale, Phillips holds 13,591 shares in the company. The shares were sold in multiple transactions, with prices ranging from $54.00 to $54.70.The sale comes as Kewaunee's stock trades near its 52-week high of $56.95, having delivered an impressive 122% return over the past year. According to InvestingPro analysis, the stock's RSI indicates overbought conditions, with the company currently valued at approximately $155 million. InvestingPro subscribers have access to 14 additional investment tips and comprehensive valuation metrics for KEQU, helping investors make more informed decisions about their investments.
In other recent news, Kewaunee Scientific Corporation has made significant strides with the acquisition of Nu Aire, a Minneapolis-based company specializing in biological safety cabinets, airflow products, and various laboratory and pharmacy equipment. The $55 million transaction is expected to strengthen Kewaunee's market presence and diversify its product offerings. This strategic expansion is seen as a transformative step for Kewaunee, enhancing its product portfolio and market reach, particularly in regions where it previously had no distribution partners.
In addition to the acquisition, Kewaunee also disclosed outcomes from its Annual Meeting of Shareholders. The company confirmed the re-election of Mr. Keith M. Gehl as a Class II director, with significant support. The appointment of Forvis Mazars, LLP as the company’s independent auditors for the fiscal year 2025 was ratified, and the compensation of the company’s named executive officers received advisory approval. These are among the recent developments within the corporation.
While Kewaunee and Nu Aire's strengths are expected to align well, the companies have also emphasized their commitment to addressing the evolving needs of laboratory environments and capitalizing on ongoing investments in life sciences, healthcare, and education sectors globally. The acquisition, backed by PNC Bank and advised by K&L Gates LLP and Carl Marks Securities LLC, is anticipated to foster sustainable growth for Kewaunee.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.